Candel Therapeutics
CADL
CADL
52 hedge funds and large institutions have $46.4M invested in Candel Therapeutics in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.83% more ownership
Funds ownership: 20.03% → 20.86% (+0.83%)
16% less call options, than puts
Call options by funds: $803K | Put options by funds: $957K
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
52
Holding in Top 10
1
Calls
$803K
Puts
$957K
Top Buyers
| 1 | +$2.11M | |
| 2 | +$2.1M | |
| 3 | +$939K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$885K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$799K |
Top Sellers
| 1 | -$2.19M | |
| 2 | -$355K | |
| 3 | -$226K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$162K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$160K |